This announcement is a separate document:
迈普医学:2024年半年度业绩预告
Medprin Regenerative Medical Technologies: 2024 Interim Performance Forecast
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.